TY - JOUR
T1 - Enantioconvergent Cross-Electrophile Coupling of 2-Aryloxetanes with Aryl and Vinyl Halides, or Anhydrides
AU - Zhang, Linli
AU - Wang, Weichen
AU - Shen, Chaoren
AU - Dong, Kaiwu
N1 - Publisher Copyright:
© 2025 American Chemical Society.
PY - 2025/5/2
Y1 - 2025/5/2
N2 - Catalytic enantioselective transformations of small heterocycles continue to be the fundamental goal in synthetic chemistry. While considerable advancements have been achieved in catalytic cross-electrophile coupling of epoxides, the analogous potential to oxetanes remains a substantially untapped frontier, probably due to their high activation energy. Herein, an unprecedented Ti/Ni/photoredox-catalyzed stereoconvergent cross-electrophile coupling of 2-aryloxetanes with (hetero)aryl and vinyl halides, or anhydrides, was developed, providing an appealing approach for the synthesis of diverse γ,γ-disubstituted alcohols or esters suitable for good yields with high enantioselectivity (>60 examples, up to 89% yield, 97% ee). The coupling products could be readily transformed to the chiral intermediates of marketed drugs sertraline and indatraline, as well as a modulator of CCR5 receptor activity.
AB - Catalytic enantioselective transformations of small heterocycles continue to be the fundamental goal in synthetic chemistry. While considerable advancements have been achieved in catalytic cross-electrophile coupling of epoxides, the analogous potential to oxetanes remains a substantially untapped frontier, probably due to their high activation energy. Herein, an unprecedented Ti/Ni/photoredox-catalyzed stereoconvergent cross-electrophile coupling of 2-aryloxetanes with (hetero)aryl and vinyl halides, or anhydrides, was developed, providing an appealing approach for the synthesis of diverse γ,γ-disubstituted alcohols or esters suitable for good yields with high enantioselectivity (>60 examples, up to 89% yield, 97% ee). The coupling products could be readily transformed to the chiral intermediates of marketed drugs sertraline and indatraline, as well as a modulator of CCR5 receptor activity.
KW - asymmetric cross-electrophile coupling
KW - CpTiCl
KW - nickel/photoredox catalysis
KW - oxetanes
KW - γ,γ-diaryl propanols
UR - https://www.scopus.com/pages/publications/105003502693
U2 - 10.1021/acscatal.5c01133
DO - 10.1021/acscatal.5c01133
M3 - 文章
AN - SCOPUS:105003502693
SN - 2155-5435
VL - 15
SP - 7578
EP - 7587
JO - ACS Catalysis
JF - ACS Catalysis
IS - 9
ER -